$16.080
+1.032 (+6.42%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
AKTS 相似图表分析预测
Alphio's AKTS stock price prediction model matches the current Aktis Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.01 (-0.46%). The 1-week path is $15.69 (-2.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Aktis Oncology Inc 股票吗？
Aktis Oncology (AKTS) is currently not a strong buy due to its low current price of $15.06, which is significantly below analyst price targets of $40 and $35. However, the RSI is extremely low at 8.904, indicating potential oversold conditions, which could suggest a rebound in the future. The main risk is the company's negative earnings, with a net income of -24,144,000 USD reported for Q2 2026, which raises concerns about its financial health.
AKTS 股价于 Tuesday 收于 $16.08，此前上涨 +6.42%
Aktis Oncology Inc (AKTS) last closed at $16.08, gaining +6.42%. These facts feed the 1-day and 1-week AKTS price prediction above.
分析师一致预期
Aktis Oncology Inc（AKTS）：买入 3、持有 0、卖出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
Aktis Oncology Inc（AKTS）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 AKTS 最接近的股票，按相似度排序。
AKTS 季节性分析
Historically the probability of a positive October return for AKTS is 0.00%. August offers the highest probability of a positive month at 46.51%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。